信息搜索
信息关键字:医
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]

·医药生物行业周报:集采为创新药腾出支付空间,多项政策为创新药发展保驾护航2023-9-25 15:34:38
·医药生物行业周报:政策催化情绪修复,关注海外业务占比高的上市公司2023-9-25 14:06:47
·万邦医药今日成功登陆深交所 致力于发展成为全球客户信任的CRO2023-9-25 14:02:45
·医药生物行业跟踪周报:GLP1靶点热度高,重点推荐信达生物、华东医药等2023-9-25 13:14:55
·医药生物行业周报:关注具有长期投资价值公司的底部布局机会2023-9-25 12:41:04
·百洋医药(301015)9月22日主力资金净卖出31.86万元2023-9-25 10:32:58
·年内11家上市川企抛出股份回购计划 医药生物和汽车行业公司意愿较强2023-9-25 1:59:59
·金域医学董事长梁耀铭:粤商以高质量发展探索中国式现代化的广东路径2023-9-24 21:57:35
·警惕“医疗”诈骗陷阱 东软医疗声明从未开设投资理财APP平台2023-9-24 21:43:01
·爱博医疗(688050)9月22日主力资金净卖出594.70万元2023-9-24 21:18:03
·赛诺医疗(688108)9月22日主力资金净买入108.43万元2023-9-24 20:55:42
·艾力斯:医疗反腐对公司影响较小,长期来看有利于推动行业长期健康化、规范化发展2023-9-24 20:46:53
·之江生物通过数字化驱动、AI智能方案、数字孪生共探智慧医疗未来发展2023-9-21 21:47:22
·中瑞药业拟将所持有的唐山利康药业有限责任公司22.5%的股权以1900万转让给河北顺泽医药有限公司2023-9-21 18:50:33
·九安医疗:美国子公司中标1.67亿美元试剂盒项目2023-9-21 13:42:44
·华为云发布汽车大模型和医学大模型2023-9-21 12:23:15
·华为发布盘古汽车大模型和医学大模型2023-9-21 11:39:41
·医药板块遭主力资金净流出超10亿元2023-9-21 11:04:07
·汇博医疗股东朱天钢质押530万股用于公司经营及业务发展的正常需要2023-9-20 21:58:38
·国家药监局召开加强第二类医疗器械注册管理工作会议2023-9-20 20:02:13

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]